SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-016864
Filing Date
2020-08-06
Accepted
2020-08-06 16:08:46
Documents
77
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20200630b_10q.htm 10-Q 1094873
2 EXHIBIT 31.1 ex_194467.htm EX-31.1 16836
3 EXHIBIT 32.1 ex_194468.htm EX-32.1 9555
10 pipeline20q1b.jpg GRAPHIC 33486
  Complete submission text file 0001437749-20-016864.txt   5747718

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT vxrt-20200630.xml EX-101.INS 1020578
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20200630.xsd EX-101.SCH 70079
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20200630_cal.xml EX-101.CAL 45699
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20200630_def.xml EX-101.DEF 450578
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20200630_lab.xml EX-101.LAB 392361
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20200630_pre.xml EX-101.PRE 479497
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 201081649
SIC: 2836 Biological Products, (No Diagnostic Substances)